Entero Healthcare
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Entero Healthcare Solutions is strategically positioning itself for robust growth through its expansion into the MedTech sector, which is expected to significantly enhance revenue streams. Management has articulated a clear vision, projecting a 23% revenue growth for FY27, driven by recent acquisitions and a focus on operational efficiencies. The integration of MedTech into its operations is anticipated to bolster margins, with a target EBITDA margin of 5.0%. However, execution risks associated with these acquisitions and increased competition in the MedTech space present potential challenges. Vista's financial outlook reflects a stable margin environment, with revenue growth moderating relative to historical performance, yet the company's strategic initiatives support a positive trajectory. The healthcare sector's overall growth, coupled with favorable macroeconomic conditions in India, further underpins Entero's outlook. Over the next 12-24 months, key opportunities include leveraging MedTech acquisitions for market share expansion, while watchpoints include the successful integration of these acquisitions and managing competitive pressures. Overall, Entero is well-positioned for growth, but must navigate the complexities of its aggressive strategy
Why We Like This Stock
- Strategic expansion into the MedTech sector is expected to enhance revenue and market presence
- Management's target of 23% revenue growth for FY27 reflects confidence in operational efficiencies and acquisition synergies
- Favorable macroeconomic conditions in India support a positive growth trajectory for the healthcare sector
Things To Watch Out For
- Execution risks associated with the integration of multiple acquisitions could impact short-term performance
- Increased competition in the MedTech sector may pressure margins and affect profitability
- Higher finance costs due to increased debt levels could pose challenges to cash flow management
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 3,922 | 5,096 | 6,591 | 7,323 | 8,599 |
| Profit Before Tax (Cr.) | 36 | 139 | 187 | 265 | 294 |
| PBT Margin | 0.9% | 2.7% | 283.7% | 3.6% | 3.4% |
| Net Profit (Cr.) | 22 | 112 | 125 | 176 | 147 |
| Earnings Per Share | 4.9 | 22.9 | 21.6 | 30.4 | 33.8 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Jeffries | ▲ Buy | 1,800 | 11-Aug-2026 |
Company Overview
Show Company Profile
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital thermometers. In addition, the company offers healthcare products, including pharmaceutical and nutraceutical products, vaccines, medical devices, such as orthopaedic implants and coronary stents, and hospital consumables comprising examination and surgical gloves, syringes, needles and sutures to hospitals, retail pharmacies, healthcare product manufacturers, and healthcare clinics. Entero Healthcare Solutions Limited was incorporated in 2018 and is based in Mumbai, India.